| 常用名 | 5-氯-N-(3-氯苯基)-2-羟基苯甲酰胺 | CAS号 | 22203-98-1 |
|---|---|---|---|
| 价格 | $需询单/100g $需询单/1kg $需询单/100kg $需询单/1000kg | 纯度 | 98.0% |
| 备货期 | 需询单 | 库存 | 询单 |
| 产品详情(用途,包装等)
用途: SARS-CoV-2-IN-14 (compound 6) is a potent inhibitor of SARS-CoV-2 with an IC50 of 0.39 μM. SARS-CoV-2-IN-14 is a niclosamide analogue. SARS-CoV-2-IN-14 contains higher stability in human plasma and liver S9 enzymes assay than niclosamide, which can improve bioavailability and half-life when administered orally[1]. 物理化学性质: CAS号:22203-98-1 常用中文名:5-氯-N-(3-氯苯基)-2-羟基苯甲酰胺 常用英文名:Benzamide,5-chloro-N-(3-chlorophenyl)-2-hydroxy 分子式:C13H9Cl2NO2 分子量:282.12 密度:1.479g/cm3 沸点:361.5ºC at 760 mmHg 熔点:N/A 闪点:172.4ºC 储存条件:2-8°C |